KINETICS OF IL-7 AND IL-15 LEVELS AFTER ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (ALLO-PBSCT) FOLLOWING HIGH-DOSE OR NONMYELOABLATIVE CONDITIONING

被引:1
|
作者
De Bock, M. [1 ]
Fillet, M. [1 ]
Merville, M-P [1 ]
Gothot, A. [1 ]
Beguin, Y. [1 ]
Baron, F. [1 ]
机构
[1] Univ Liege, B-4000 Liege, Belgium
关键词
D O I
10.1016/j.bbmt.2011.12.194
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
193
引用
收藏
页码:S275 / S275
页数:1
相关论文
共 50 条
  • [31] High-dose chemotherapy with peripheral blood stem cell transplantation (HDC/PBSCT) for mantle cell lymphoma (MCL).
    Frakes, L
    Miller, W
    McMillan, R
    Meisenberg, B
    BLOOD, 1996, 88 (10) : 3859 - 3859
  • [32] Effects of lenograstim or filgrastim on blood cell recovery after high-dose chemotherapy (HDC) and autologous peripheral blood stem cell transplantation (PBSCT)
    Bojko, Peter
    Huettmann, Andreas
    Schirsafi, Kasra
    Seeber, Siegfried
    ANNALS OF ONCOLOGY, 2004, 15 : 223 - 223
  • [33] CMV infection following allogeneic peripheral blood stem cell transplantation (allo-PBSCT): Changing patterns and low dose short course (LDSC) gancyclovir (GCV)as an effective nontoxic presumtive therapy (PT) regimen.
    Vij, R
    Adkins, D
    Brown, R
    Khoury, H
    Westervelt, P
    Goodnough, L
    Abidi, M
    DiPersio, J
    BLOOD, 2000, 96 (11) : 189A - 189A
  • [34] IL-7 and IL-15 levels reflect the degree of T-cell depletion during lymphopenia and drive expansion of effector memory T cells after allogeneic HSCT
    Kielsen, Katrine
    Oostenbrink, Lisa V. E.
    Jansen-Hoogendijk, Anja M.
    van Ostaijen-ten Dam, Monique M.
    Ifversen, Marianne
    Heilmann, Carsten
    Schilham, Marco W.
    van Halteren, Astrid G. S.
    Bredius, Robbert G. M.
    Lankester, Arjan C.
    Jol-van der Zijde, Cornelia M.
    van Tol, Maarten J. D.
    Mueller, Klaus
    BONE MARROW TRANSPLANTATION, 2019, 54 : 476 - 477
  • [35] Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)
    Voso, MT
    Martin, S
    Hohaus, S
    Abdallah, A
    Schlenk, RF
    Ho, AD
    Haas, R
    BONE MARROW TRANSPLANTATION, 2000, 25 (09) : 957 - 964
  • [36] Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT)
    MT Voso
    S Martin
    S Hohaus
    A Abdallah
    RF Schlenk
    AD Ho
    R Haas
    Bone Marrow Transplantation, 2000, 25 : 957 - 964
  • [37] Infections profile after allogeneic peripheral blood stem cell transplantation (allo-PBSCT) from matched or partially mismatched donor and post-transplant Cyclophosphamide (PTCY): a single Institution experience
    Gallo, Susanna
    Caravelli, Daniela
    Becco, Paolo
    Vassallo, Elena
    Coha, Valentina
    Mangioni, Monica
    Berger, Massimo
    Polo, Alessandra
    Frascione, Pio Manlio Mirko
    Salierno, Milena
    Carraro, Francesca
    Crotto, Luca
    Aglietta, Massimo
    Fagioli, Franca
    Carnevale-Schianca, Fabrizio
    BONE MARROW TRANSPLANTATION, 2018, 53 : 564 - 564
  • [38] Immune reconstitution after high-dose chemotherapy (HDCT) followed by autologous peripheral stem cell transplantation (PBSCT).
    Reimer, P
    Kunzmann, V
    Weissinger, F
    Wilhelm, M
    BLOOD, 2000, 96 (11) : 402A - 403A
  • [39] Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantation
    N Piccirillo
    S De Matteis
    S De Vita
    L Laurenti
    P Chiusolo
    F Sorà
    G Reddiconto
    G d'Onofrio
    G Leone
    S Sica
    Bone Marrow Transplantation, 2007, 40 : 579 - 583
  • [40] Kinetics of peg-filgrastim after high-dose chemotherapy and autologous peripheral blood stem cell transplantation
    Piccirillo, N.
    De Matteis, S.
    De Vita, S.
    Laurenti, L.
    Chiusolo, P.
    Sora, F.
    Reddiconto, G.
    d'Onofrio, G.
    Leone, G.
    Sica, S.
    BONE MARROW TRANSPLANTATION, 2007, 40 (06) : 579 - 583